Adherence to laboratory monitoring among people taking oral drugs for multiple sclerosis: A Canadian population-based study.

Huah Shin NgElaine KingwellFeng ZhuTingting ZhangKathryn C FitzgeraldRobert CarruthersHelen Tremlett

Published in: Multiple sclerosis (Houndmills, Basingstoke, England) (2020)

Adherence to recommended laboratory testing was high (>77%) before oral DMT initiation, but lower once on drug. There is a need to understand the long-term consequences of suboptimal laboratory monitoring and sex differences in the DMT-treated MS population.

Keyphrases

multiple sclerosis
mass spectrometry
ms ms
glycemic control
type diabetes
emergency department
drug induced
adipose tissue
weight loss